EUVIMED · CrossrefZeitschrift
Journal of Child and Adolescent Psychopharmacology
ISSN 1044-5463 · SAGE Publications
Neueste Artikel
Clozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study
Efficacy of Centanafadine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and High Executive Dysfunction: A Post Hoc Analysis of Two Phase 3 Trials
Manganese Exposure and Attention-Deficit/Hyperactivity Disorder-Related Neurobehavioral Outcomes in Children: A Systematic Review of Human Studies
Antipsychotic Use During Catatonia in Youth with Neurodevelopmental Disorders and Psychotic Symptoms: A 20-Patient Case Series
Relationships Between Cognitive Disengagement Syndrome, Impulsivity, and Emotion Regulation Among Adolescents
Emotional Abuse as an Upstream Factor Influencing Non-Suicidal Self-Injury in Depressed Adolescents: A Network Analysis
Knowledge, Skills, Attitudes, and Perceived Barriers Related to Clozapine Use Among Child and Adolescent Psychiatry Professionals: A Cross-Sectional Survey
Letter: Evolving Clinical Evidence: Electroencephalography Abnormalities in Autism Spectrum Disorder and the Emerging Role of Neuroelectric Biomarkers in Psychiatry
Safety and Effectiveness of Clozapine in Youth and Young Adults with Neurodevelopmental Disorders and Severe, Treatment-Refractory Irritability and Aggression: A Retrospective Chart Review
Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder
Pain in Tourette Syndrome: A Comprehensive Review
Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms
A Short-Term Group Telehealth Cognitive Behavioral Therapy Intervention for Youth with Autism and Anxiety: A Pilot Study
Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials
A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth
Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis
From the Editor-in-Chief’s Desk: Are Omega-3 Fatty Acid Supplements an Effective, Safe, and Scalable Treatment for Depression in Children and Adolescents?
Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study
Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review
Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders
Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression
The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder
Factors Associated with Symptom Persistence in PANS: Part I—Access to Care
The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression
Psychopharmacological Treatment Algorithms of Manic/Mixed and Depressed Episodes in Pediatric Bipolar Disorder
A Survey of Demographics, Symptom Course, Family History, and Barriers to Treatment in Children with Pediatric Acute-Onset Neuropsychiatric Disorders and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections
Sex and Aggression Characteristics in a Cohort of Patients with Pediatric Acute-Onset Neuropsychiatric Syndrome
A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors
Jahrgänge
2026 · 652025 · 932024 · 722023 · 702022 · 742021 · 982020 · 932019 · 1132018 · 1072017 · 1432016 · 1732015 · 1422014 · 1162013 · 1172012 · 812011 · 902010 · 812009 · 1112008 · 842007 · 1072006 · 932005 · 1172004 · 1012003 · 782002 · 502001 · 532000 · 431999 · 381998 · 341997 · 271996 · 301995 · 321994 · 381993 · 271992 · 441991 · 151990 · 44
EUVIMED